| scholarly article | Q13442814 |
| P50 | author | David Ian Stuart | Q21165826 |
| Jingshan Ren | Q55457778 | ||
| Abhay Kotecha | Q56437387 | ||
| Donald P King | Q42981100 | ||
| P2093 | author name string | Elizabeth E Fry | |
| Emiliana Brocchi | |||
| Alison Burman | |||
| Stephen Berryman | |||
| Terry Jackson | |||
| Eleanor M Cottam | |||
| Andrew M Q King | |||
| Ray Owens | |||
| Amin S Asfor | |||
| Gareth Shimmon | |||
| Joseph Newman | |||
| Sarah Gold | |||
| Toby J Tuthill | |||
| P2860 | cites work | Production of functional chimaeric mouse/human antibody | Q59080874 |
| Canonical structures for the hypervariable regions of immunoglobulins | Q69450418 | ||
| The predicted structure of immunoglobulin D1.3 and its comparison with the crystal structure | Q70300738 | ||
| Conformation of complementarity determining region L1 loop in murine IgG lambda light chain extends the repertoire of canonical forms | Q70561178 | ||
| Pen-side test for investigating FMD | Q74248511 | ||
| Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies | Q45847271 | ||
| Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites | Q45848027 | ||
| Epitopes on foot-and-mouth disease virus particles. I. Topology | Q45848103 | ||
| Structural families in loops of homologous proteins: automatic classification, modelling and application to antibodies | Q47628564 | ||
| Antibody-antigen interactions: contact analysis and binding site topography. | Q47628744 | ||
| Framework residue 71 is a major determinant of the position and conformation of the second hypervariable region in the VH domains of immunoglobulins | Q47639980 | ||
| Structural determinants of the conformations of medium-sized loops in proteins | Q47643263 | ||
| Relationship between loss of heavy chains and the appearance of nonproducing hybridomas | Q47864915 | ||
| Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease | Q56958645 | ||
| Velvet: algorithms for de novo short read assembly using de Bruijn graphs | Q24657623 | ||
| A pipeline for the production of antibody fragments for structural studies using transient expression in HEK 293T cells | Q27651371 | ||
| Rational Engineering of Recombinant Picornavirus Capsids to Produce Safe, Protective Vaccine Antigen | Q27677139 | ||
| Electron counting and beam-induced motion correction enable near-atomic-resolution single-particle cryo-EM. | Q27677990 | ||
| Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design | Q27702186 | ||
| Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6 A | Q27729072 | ||
| Structure of a major immunogenic site on foot-and-mouth disease virus | Q27732027 | ||
| Fast gapped-read alignment with Bowtie 2 | Q27860699 | ||
| EMAN: semiautomated software for high-resolution single-particle reconstructions | Q27860772 | ||
| Accurate determination of local defocus and specimen tilt in electron microscopy | Q27861008 | ||
| Standard conformations for the canonical structures of immunoglobulins | Q28254522 | ||
| Conformations of immunoglobulin hypervariable regions | Q28273335 | ||
| Reshaping human antibodies for therapy | Q28290936 | ||
| Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus | Q28776703 | ||
| RELION: implementation of a Bayesian approach to cryo-EM structure determination | Q29547673 | ||
| Automated electron microscope tomography using robust prediction of specimen movements | Q29616585 | ||
| Truncated Bovine Integrin Alpha-v/Beta-6 as a Universal Capture Ligand for FMD Diagnosis | Q30151862 | ||
| Analysis of the antigen combining site: correlations between length and sequence composition of the hypervariable loops and the nature of the antigen | Q30720034 | ||
| Rules of engagement between αvβ6 integrin and foot-and-mouth disease virus | Q30854552 | ||
| Making antibody fragments using phage display libraries | Q33392386 | ||
| Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains | Q33392787 | ||
| Foot-and-mouth disease: past, present and future | Q33640554 | ||
| Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor. | Q33782587 | ||
| Cloning immunoglobulin variable domains for expression by the polymerase chain reaction | Q33859027 | ||
| Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus | Q34294547 | ||
| The economic impacts of foot and mouth disease - what are they, how big are they and where do they occur? | Q34365052 | ||
| The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution | Q34446528 | ||
| Structure and receptor binding. | Q35044853 | ||
| Evolution of foot-and-mouth disease virus | Q35044856 | ||
| Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells | Q35838328 | ||
| Chapter 3. High-throughput protein purification for x-ray crystallography and NMR. | Q36005752 | ||
| Microneutralization tests for serological typing and subtyping of foot-and-mouth disease virus strains | Q36250679 | ||
| An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity | Q36270017 | ||
| Structure of the complex of an Fab fragment of a neutralizing antibody with foot-and-mouth disease virus: positioning of a highly mobile antigenic loop | Q36857671 | ||
| Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains | Q37576261 | ||
| Development of vaccines toward the global control and eradication of foot-and-mouth disease. | Q37857258 | ||
| The pathogenesis of foot-and-mouth disease II: viral pathways in swine, small ruminants, and wildlife; myotropism, chronic syndromes, and molecular virus-host interactions. | Q37889405 | ||
| Synthetic antibody technologies | Q38203703 | ||
| Direct detection and characterization of foot-and-mouth disease virus in East Africa using a field-ready real-time PCR platform. | Q38652385 | ||
| Novel antibody binding determinants on the capsid surface of serotype O foot-and-mouth disease virus. | Q38711121 | ||
| Specificity of the VP1 GH loop of Foot-and-Mouth Disease virus for alphav integrins. | Q38760885 | ||
| Global Foot-and-Mouth Disease Research Update and Gap Analysis: 4 - Diagnostics. | Q38851213 | ||
| Transient mammalian cell transfection with polyethylenimine (PEI). | Q39099315 | ||
| The epithelial integrin alphavbeta6 is a receptor for foot-and-mouth disease virus | Q39584959 | ||
| Analysis of neutralizing epitopes on foot-and-mouth disease virus. | Q40128164 | ||
| Antigenic sites on foot-and-mouth disease virus type A10. | Q40130217 | ||
| Integrin alphavbeta8 functions as a receptor for foot-and-mouth disease virus: role of the beta-chain cytodomain in integrin-mediated infection. | Q40567879 | ||
| The structure of an immunodominant loop on foot and mouth disease virus, serotype O1, determined under reducing conditions | Q40672613 | ||
| The structural repertoire of the human V kappa domain | Q40789466 | ||
| Structure of the major antigenic loop of foot-and-mouth disease virus complexed with a neutralizing antibody: direct involvement of the Arg-Gly-Asp motif in the interaction | Q40806410 | ||
| Routine application of enzyme-linked immunosorbent assay in comparison with complement fixation for the diagnosis of foot-and-mouth and swine vesicular diseases | Q41437454 | ||
| Loss of antibody productivity is highly reproducible in multiple hybridoma subclones | Q41547128 | ||
| Population balance between producing and nonproducing hybridoma clones is very sensitive to serum level, state of inoculum, and medium composition | Q41640248 | ||
| Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites | Q41717447 | ||
| SAbPred: a structure-based antibody prediction server | Q41723956 | ||
| A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. | Q41743263 | ||
| Foot-and-mouth disease virus forms a highly stable, EDTA-resistant complex with its principal receptor, integrin alphavbeta6: implications for infectiousness | Q41914096 | ||
| Early events in integrin alphavbeta6-mediated cell entry of foot-and-mouth disease virus | Q42069725 | ||
| Structural repertoire of the human VH segments | Q42603998 | ||
| Utility of recombinant integrin alpha v beta6 as a capture reagent in immunoassays for the diagnosis of foot-and-mouth disease | Q43435500 | ||
| Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants | Q43505521 | ||
| Validation of a recombinant integrin αvβ6/monoclonal antibody based antigen ELISA for the diagnosis of foot-and-mouth disease | Q43693139 | ||
| Rapid and simple detection of foot-and-mouth disease virus: Evaluation of a cartridge-based molecular detection system for use in basic laboratories | Q43924010 | ||
| The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells | Q44074351 | ||
| Development and laboratory validation of a lateral flow device for the detection of serotype SAT 2 foot-and-mouth disease viruses in clinical samples | Q44157566 | ||
| Converting monoclonal antibodies into Fab fragments for transient expression in mammalian cells. | Q44645362 | ||
| A hapten-specific chimaeric IgE antibody with human physiological effector function. | Q44964801 | ||
| A model for foot-and-mouth disease virus | Q45149752 | ||
| Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants | Q45294806 | ||
| Development and laboratory validation of a lateral flow device for the detection of foot-and-mouth disease virus in clinical samples | Q45390290 | ||
| The virus of foot-and-mouth disease | Q45719382 | ||
| Development of a rapid chromatographic strip test for the pen-side detection of foot-and-mouth disease virus antigen | Q45736551 | ||
| Evidence for an internal antigen in foot-and-mouth disease virus | Q45823027 | ||
| Neutralization sites of type O1 foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants | Q45842144 | ||
| Detection and typing of foot-and-mouth disease virus by enzyme-linked immunosorbent assay: a sensitive, rapid and reliable technique for primary diagnosis | Q45842301 | ||
| The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). | Q45845848 | ||
| Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites | Q45847241 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diagnosis | Q16644043 |
| P304 | page(s) | e0201853 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Generation and characterisation of recombinant FMDV antibodies: Applications for advancing diagnostic and laboratory assays | |
| P478 | volume | 13 |
| Q64080113 | Structural basis for neutralization of hepatitis A virus informs a rational design of highly potent inhibitors | cites work | P2860 |
Search more.